Financial results - TRANSMED BEST S.R.L.

Financial Summary - Transmed Best S.r.l.
Unique identification code: 32222587
Registration number: J20/836/2013
Nace: 6820
Sales - Ron
17.200
Net Profit - Ron
10.094
Employee
The most important financial indicators for the company Transmed Best S.r.l. - Unique Identification Number 32222587: sales in 2023 was 17.200 euro, registering a net profit of 10.094 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Inchirierea si subinchirierea bunurilor imobiliare proprii having the NACE code 6820.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Transmed Best S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 7.117 12.714 27.724 25.194 17.611 14.400 15.046 11.946 14.936 17.200
Total Income - EUR 7.117 12.714 27.734 26.193 18.330 14.400 15.091 11.946 15.019 17.200
Total Expenses - EUR 1.736 7.950 28.181 29.915 12.347 3.660 3.791 4.300 5.458 5.181
Gross Profit/Loss - EUR 5.381 4.764 -447 -3.723 5.983 10.740 11.300 7.646 9.561 12.019
Net Profit/Loss - EUR 5.167 4.477 -721 -3.975 5.583 10.308 10.861 7.331 9.122 10.094
Employees 0 2 3 3 1 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 15.5%, from 14.936 euro in the year 2022, to 17.200 euro in 2023. The Net Profit increased by 999 euro, from 9.122 euro in 2022, to 10.094 in the last year.

Check the financial reports for the company - Transmed Best S.r.l.

Rating financiar

Financial Rating -
Transmed Best S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Transmed Best S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Transmed Best S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Transmed Best S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Transmed Best S.r.l. - CUI 32222587

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 66.421 66.005 64.387 61.375 55.682 52.419 49.343 46.240 45.864 43.354
Current Assets 5.956 16.070 8.968 8.691 6.113 3.876 7.962 17.895 4.866 10.781
Inventories 0 3.185 4.576 3.987 0 0 0 0 0 0
Receivables 0 12.818 2.476 4.003 1.555 1.674 1.609 1.702 2.566 2.839
Cash 5.956 67 1.916 701 4.558 2.202 6.353 16.194 2.300 7.942
Shareholders Funds 72.306 77.458 62.586 53.174 57.924 48.776 48.376 54.635 9.171 19.237
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 71 4.618 10.768 16.891 3.872 7.519 8.928 9.501 41.559 34.899
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "6820 - 6820"
CAEN Financial Year 6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 10.781 euro in 2023 which includes Inventories of 0 euro, Receivables of 2.839 euro and cash availability of 7.942 euro.
The company's Equity was valued at 19.237 euro, while total Liabilities amounted to 34.899 euro. Equity increased by 10.094 euro, from 9.171 euro in 2022, to 19.237 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Transmed Best S.r.l.

Comments - Transmed Best S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.